Skip to main content
Year archive

J.B. Chemicals & Pharmaceuticals Lt — 2020 filings

All 221 regulatory filings released by J.B. Chemicals & Pharmaceuticals Lt (JBCHEPHARM) in 2020, sourced directly from the official regulator.

221 Filings
2020 Period
2020 filings (221)
Filing Released Lang
Closure of Trading Window.
Regulatory Filings
2020-12-31 English
Trading Window
Regulatory Filings
2020-12-31 English
Schedule of meeting with institutional investors/analysts
Regulatory Filings
2020-12-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2020-12-28 English
Result of Postal Ballot
Regulatory Filings
2020-12-24 English
Updates
Regulatory Filings
2020-12-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2020-12-16 English
Schedule of meeting with institutional investors/analysts
Regulatory Filings
2020-12-16 English
Intimation of loss of share certificate.
Regulatory Filings
2020-12-15 English
Loss of Share Certificates
Regulatory Filings
2020-12-15 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd
Regulatory Filings
2020-12-10 English
Related Party Transactions
Regulatory Filings
2020-11-26 English
Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the ....
Regulatory Filings
2020-11-26 English
Copy of Newspaper Publication
Regulatory Filings
2020-11-25 English
Newspaper advertisement for Postal Ballot
Regulatory Filings
2020-11-25 English
Updates
Regulatory Filings
2020-11-24 English
Issue of Postal Ballot Notice
Regulatory Filings
2020-11-24 English
Copy of Newspaper Publication
Regulatory Filings
2020-11-11 English
Newspaper cutting of extract of unaudited consolidated financial results for quarter ended on September 30, 2020
Regulatory Filings
2020-11-11 English
Issue of duplicate share certificates
Regulatory Filings
2020-11-11 English
Loss of Share Certificates
Regulatory Filings
2020-11-11 English
Company Presentation
Regulatory Filings
2020-11-10 English
Press Release
Regulatory Filings
2020-11-10 English
Investor Presentation
Regulatory Filings
2020-11-10 English
Press Release
Interim / Quarterly Report
2020-11-10 English
Appointment of Auditor
Regulatory Filings
2020-11-10 English
Resignation of Auditor
Regulatory Filings
2020-11-10 English
Resignation of a Director
Regulatory Filings
2020-11-10 English
Change in Auditors
Regulatory Filings
2020-11-10 English
Change in Auditors
Audit Report / Information
2020-11-10 English
Change in Director(s)
Board/Management Information
2020-11-10 English
Unaudited Financial Results for the quarter ended on September 30, 2020.
Regulatory Filings
2020-11-10 English
Financial Result Updates
Regulatory Filings
2020-11-10 English
Outcome of the Meeting of the Board of Directors - Unaudited Financial Results for the quarter ended on September 30, 2020.
Regulatory Filings
2020-11-10 English
Outcome of Board Meeting
Regulatory Filings
2020-11-10 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-11-10 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas
Regulatory Filings
2020-11-10 English
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November ....
Regulatory Filings
2020-11-10 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holding Pte Ltd & PACs
Regulatory Filings
2020-11-09 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2020 for Tau Investment Holdings Pte Ltd
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bharati S Mody
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirav Shirish Mody
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shirish Bhagwanlal Mody
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Purvi Uday Asher
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pranabh Dinesh Mody
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kumud Dinesh Mody
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for D B Mody HUF
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bharat P Mehta
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Bharat Mehta
Regulatory Filings
2020-11-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pallavi Bharat Mehta
Regulatory Filings
2020-11-09 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Unaudited ....
Regulatory Filings
2020-10-30 English
Board Meeting — Financial Results
Regulatory Filings
2020-10-30 English
Certificate under regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2020-10-21 English
Compliance certificate for half year ended September 30, 2020.
Regulatory Filings
2020-10-17 English
Resignation of Director
Regulatory Filings
2020-10-05 English
Appointment of Whole-time Director & Chief Executive Officer
Regulatory Filings
2020-10-05 English
Resignation
Regulatory Filings
2020-10-05 English
Appointment
Regulatory Filings
2020-10-05 English
Post Offer Public Announcement
Regulatory Filings
2020-10-01 English
Shareholders meeting
Regulatory Filings
2020-10-01 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of Post-Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India ....
Regulatory Filings
2020-10-01 English
Results of Voting at the Annual General Meeting
Regulatory Filings
2020-10-01 English
Proceedings of the Annual General Meeting.
Regulatory Filings
2020-10-01 English
Shareholders meeting
Regulatory Filings
2020-10-01 English
Trading Window
Regulatory Filings
2020-10-01 English
Closure of Trading Window
Regulatory Filings
2020-10-01 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 30, 2020 for Tau Investment ....
Regulatory Filings
2020-09-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas, Hong Kong Branch
Regulatory Filings
2020-09-29 English
Press Release
Regulatory Filings
2020-09-15 English
Press Release
Earnings Release
2020-09-15 English
Unaudited Financial Results for the quarter ended on June 30, 2020.
Regulatory Filings
2020-09-14 English
Financial Result Updates
Regulatory Filings
2020-09-14 English
Outcome of the Meeting of the Board of Directors - Unaudited Financial Results for the quarter ended on June 30, 2020.
Regulatory Filings
2020-09-14 English
Outcome of Board Meeting
Interim / Quarterly Report
2020-09-14 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial ...
Regulatory Filings
2020-09-10 English
Open Offer
M&A Activity
2020-09-10 English
Updates
Regulatory Filings
2020-09-09 English
Newspaper advertisement in connection with the notice of the annual general meeting of the Company to be held on 30-09-2020 through Video Conferencing (VC)/Other Audio Visual Means (OAVM).
Regulatory Filings
2020-09-09 English
Revised Record date
Notice of Dividend Amount
2020-09-08 English
Shareholders meeting
Regulatory Filings
2020-09-08 English
The Company has fixed September 23, 2020 as record date, to receive the final dividend for FY 2019-2020
Regulatory Filings
2020-09-08 English
Postponement of AGM to 30-9-2020 and Amended Notice of AGM
Regulatory Filings
2020-09-08 English
Public Announcement-Open Offer
M&A Activity
2020-09-07 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/09/2020 ,inter alia, to consider and approve Unaudited ....
Regulatory Filings
2020-09-05 English
Board Meeting — Financial Results
Regulatory Filings
2020-09-05 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of dispatch advertisement published on September 5, 2020 for the attention of the Public Shareholders of JB Chemicals ....
Regulatory Filings
2020-09-05 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 04, 2020 for Tau Investment ....
Regulatory Filings
2020-09-04 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").
Regulatory Filings
2020-09-04 English
Open Offer
Regulatory Filings
2020-09-04 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas
Regulatory Filings
2020-09-02 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2020-09-01 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investments Holdings Pte Ltd & PACs
Regulatory Filings
2020-09-01 English
The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holdings Pte Ltd
Regulatory Filings
2020-09-01 English
Updates
Board/Management Information
2020-09-01 English
Resignation of Independent Directors
Regulatory Filings
2020-09-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Namplas Chemicals Pvt Ltd
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Synit Drugs Pvt Ltd
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mody Trading Co.
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mody Bros. Held by Pranabh D Mody - Partner
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepali Family Trust
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Uday Madhavdas Asher
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Boxcare Packagings Pvt Ltd
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priti Family Trust
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shirish Bhagwanlal Mody
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priti Rajen Shah
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for P D Mody HUF
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sejal Pranabh Mody
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jinali Pranabh Mody
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pranabh Dinesh Mody
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Purvi Uday Asher
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for D B Mody HUF
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kumud Dinesh Mody
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bharat P Mehta
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Bharat Mehta
Regulatory Filings
2020-08-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pallavi Bharat Mehta
Regulatory Filings
2020-08-31 English
Updates
Regulatory Filings
2020-08-31 English
Change in Board of Directors
Regulatory Filings
2020-08-31 English
Updates
Regulatory Filings
2020-08-28 English
Open Offer by Tau Investment Holdings Pte. Ltd.-Extension of time for dispatch of Letter of Offer granted by SEBI
Regulatory Filings
2020-08-28 English
Updates
Regulatory Filings
2020-08-28 English
Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited
Regulatory Filings
2020-08-28 English
Updates
Regulatory Filings
2020-08-27 English
Submission of recommendation of Committee of Independent Directors ('IDC') under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended.
Regulatory Filings
2020-08-27 English
Updates
Regulatory Filings
2020-08-18 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2020-08-18 English
JB Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2020 to September 24, 2020 (both ....
Regulatory Filings
2020-08-18 English
Record Date
Notice of Dividend Amount
2020-08-16 English
Updates
AGM Information
2020-08-16 English
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2020-08-16 English
Notice of Annual General Meeting
Regulatory Filings
2020-08-16 English
Submission of Annual Report for the year 2019-20
Regulatory Filings
2020-08-16 English
Updates
Regulatory Filings
2020-08-15 English
Notice in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).
Regulatory Filings
2020-08-15 English
Updates
Regulatory Filings
2020-08-14 English
Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).
Regulatory Filings
2020-08-14 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-07-28 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pallavi Bharat Mehta
Regulatory Filings
2020-07-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pallavi Bharat Mehta
Regulatory Filings
2020-07-28 English
Demise
Board/Management Information
2020-07-22 English
Demise of Chairman & Managing Director Shri Jyotindra B. Mody
Regulatory Filings
2020-07-22 English
Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the ....
Regulatory Filings
2020-07-18 English
Related Party Transactions
Regulatory Filings
2020-07-18 English
ICICI Securities Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company").
Regulatory Filings
2020-07-15 English
Updates
Capital/Financing Update
2020-07-14 English
Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited
Regulatory Filings
2020-07-14 English
Public Announcement-Open Offer
Regulatory Filings
2020-07-09 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of detailed Public Statement in terms of Regulation 3(1), Regulation 4 read with Regulation 13(4), Regulation ....
Regulatory Filings
2020-07-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for D B Mody HUF (Karta, Pranabh Dinesh Mody)
Regulatory Filings
2020-07-07 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pranabh Dinesh Mody & Purvi Uday Asher
Regulatory Filings
2020-07-07 English
Updates
M&A Activity
2020-07-02 English
Public Announcement of open offer for acquisition of Company's Equity Shares
Regulatory Filings
2020-07-02 English
Open Offer
Regulatory Filings
2020-07-02 English
ICICI Securities Ltd ("Manager to Open Offer") has submitted to BSE a copy of Public Announcement under Regulation 3(1) and Regulation 4 read with Regulation 13(1) and Regulation 15(1) ....
Regulatory Filings
2020-07-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2020-06-26 English
Conference call for investors/ analysts on July 6, 2020 at 4:00 pm in relation to audited financial results/ financial statements of the Company for the quarter/ year ended on March 31, 2020
Regulatory Filings
2020-06-26 English
Investor presentation on consolidated performance during quarter and year ended on March 31, 2020.
Regulatory Filings
2020-06-25 English
Investor Presentation
Investor Presentation
2020-06-25 English
Financial Result Updates
Regulatory Filings
2020-06-25 English
Audited Financial Results for the quarter and year ended on March 31, 2020.
Regulatory Filings
2020-06-25 English
Audited Financial Results for the quarter and year ended on March 31, 2020.
Regulatory Filings
2020-06-25 English
Outcome of Board Meeting
Regulatory Filings
2020-06-25 English
Dividend Updates
Notice of Dividend Amount
2020-06-25 English
Recommendation of final dividend of Re. 1 per share of FV Rs. 2 (50%) for FY 2019-20
Regulatory Filings
2020-06-25 English
Annual Secretarial Compliance Report for the financial year ended on March 31, 2020.
Regulatory Filings
2020-06-19 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2020-06-16 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for D B Mody HUF (Karta, Pranabh Dinesh Mody)
Regulatory Filings
2020-06-16 English
Board of Directors of the Company at its meeting to be held on June 25, 2020, would also consider recommendation of final dividend for the F.Y. 2019-20.
Regulatory Filings
2020-06-11 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/06/2020 ,inter alia, to consider and approve audited financial ....
Regulatory Filings
2020-06-11 English
Board Meeting — Dividend
Notice of Dividend Amount
2020-06-11 English
Board Meeting — Financial Results
Regulatory Filings
2020-06-11 English
Certificate under regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2020-05-06 English
Updates
Regulatory Filings
2020-04-27 English
ANDA approval by US FDA
Regulatory Filings
2020-04-27 English
Compliance certificate for the half year ended March 31, 2020.
Regulatory Filings
2020-04-22 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2020-04-20 English
Updates
Environmental & Social Information
2020-04-15 English
Contribution to PM Cares Fund
Regulatory Filings
2020-04-15 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification
2020-04-07 English
Updates
Legal Proceedings Report
2020-04-03 English
Supreme Court judgement on orders passed by National Green Tribunal
Regulatory Filings
2020-04-03 English
Updates
Regulatory Filings
2020-04-02 English
News about Ranitidine formulations in the US
Regulatory Filings
2020-04-02 English
This is to inform you that as per Company's code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of ....
Regulatory Filings
2020-04-01 English
Trading Window
Regulatory Filings
2020-04-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2020-02-20 English
Institutional investors meet
Regulatory Filings
2020-02-20 English
Record Date
Notice of Dividend Amount
2020-02-20 English
The Company has fixed March 4, 2020 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company's shares to receive the interim dividend for ....
Regulatory Filings
2020-02-20 English
The Company has fixed March 4, 2020 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company's shares to receive the interim dividend for ....
Regulatory Filings
2020-02-20 English
Dividend
Notice of Dividend Amount
2020-02-20 English
Declaration of interim dividend @ Rs. 10 per equity share of FV Rs. 2 each
Regulatory Filings
2020-02-20 English
Updates
Regulatory Filings
2020-02-11 English
US FDA approval of New Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat
Regulatory Filings
2020-02-11 English
Updates
Regulatory Filings
2020-02-10 English
Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat
Regulatory Filings
2020-02-10 English
Trading Window
Regulatory Filings
2020-02-06 English
Intimation of Trading Window Closure period
Regulatory Filings
2020-02-06 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/02/2020 ,inter alia, to consider and approve to consider ....
Regulatory Filings
2020-02-05 English
Board Meeting — Dividend
Regulatory Filings
2020-02-05 English
Investor Presentation
Interim / Quarterly Report
2020-02-04 English
Investor Presentation on consolidated financial results during quarter ended December 31, 2019.
Regulatory Filings
2020-02-04 English
Acquisition of trademarks
Regulatory Filings
2020-02-04 English
Investor Presentation
Regulatory Filings
2020-02-04 English
Updates
Regulatory Filings
2020-02-04 English
Unaudited Financial Results for quarter ended December 31, 2019
Regulatory Filings
2020-02-04 English
Financial Result Updates
Regulatory Filings
2020-02-04 English
Outcome of Board Meeting
Regulatory Filings
2020-02-04 English
Outcome of Board Meeting
Regulatory Filings
2020-02-04 English
Schedule of meeting with institutional investors
Regulatory Filings
2020-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2020-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2020-01-28 English
Schedule of meeting with institutional investors
Regulatory Filings
2020-01-28 English
Earnings call
Regulatory Filings
2020-01-28 English
Information of loss of shares
Regulatory Filings
2020-01-22 English
Certificate of extinguishment of Equity Shares bought back by the Company
Regulatory Filings
2020-01-13 English
Post Buyback Public Announcement
Regulatory Filings
2020-01-09 English
Post buyback Public Announcement
Regulatory Filings
2020-01-09 English
Trading Window
Regulatory Filings
2020-01-06 English
Board Meeting — Financial Results
Regulatory Filings
2020-01-06 English
Intimation of closure of Trading Window period.
Regulatory Filings
2020-01-06 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2020 ,inter alia, to consider and approve Unaudited ....
Regulatory Filings
2020-01-06 English